GT Molecular Enters Cancer Molecular Assay Market
GT Molecular, Inc. is entering the cancer molecular assay market with multi-target PCR kits featuring quality control metrics.
Read MorePosted by Chris Wolski | Jun 1, 2023 | Molecular Diagnostics |
GT Molecular, Inc. is entering the cancer molecular assay market with multi-target PCR kits featuring quality control metrics.
Read MorePosted by Chris Wolski | May 30, 2023 | POC Rapid Assays |
The CDC’s OneLab TEST is designed for anyone who performs or coordinates diagnostic testing at non-laboratory sites.
Read MorePosted by Melanie Hamilton-Basich | May 29, 2023 | Molecular Diagnostics |
Roche showcased some of its new and future innovative laboratory solutions and digital diagnostics at this year’s WorldLab-EuroMedLab 2023.
Read MorePosted by Melanie Hamilton-Basich | May 26, 2023 | Sexually Transmitted Diseases |
Simple HealthKit has launched an at-home test for five common STIs: chlamydia, gonorrhea, trichomoniasis, HIV, and syphilis.
Read MorePosted by Chris Wolski | May 25, 2023 | Molecular Diagnostics |
The award through the NIH’s RADx Tech program, will support Domus Diagnostics’ at-home molecular test for clinical trial readiness.
Read More